Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by Accountprinceon Jul 14, 2023 2:24pm
322 Views
Post# 35541697

Our 56% Guy Doing a Financing?

Our 56% Guy Doing a Financing?Sure looks like he's about to overshadow his previous pathetic raises.  No wonder close to a majority want to be rid of him and his cronies in underachievement.  Good thing the prospects remain the same.  As MM said FDA approval of PMX is getting very close to being a certainty.  Love the Company and its prospects and Baxter circling around our PMX prize.  The reward will be very handsome in the next few months.  If there was even a shred of financial competence within the group of 56 percenters this raise would be happening at a price north of $1 per share.

Getting very tired of this unpopular group of 56percenters.  When do we get another shot at voting this guy and co out?  Won't be too soon for me.  Have to get the powder dry to grab some to fight the dilution that seems to be around the corner. 
<< Previous
Bullboard Posts
Next >>